Two multiple sclerosis cases developed herpes zoster during use of fingolimod
dc.authorscopusid | 23062131200 | |
dc.authorscopusid | 8944423400 | |
dc.authorscopusid | 56042671700 | |
dc.authorscopusid | 57189598520 | |
dc.authorscopusid | 58505968100 | |
dc.contributor.author | Terzi, Murat | |
dc.contributor.author | Duman, Taşkın | |
dc.contributor.author | Şen, Sedat | |
dc.contributor.author | Güntel, Murat | |
dc.contributor.author | Şen, Nalan Örtücü | |
dc.date.accessioned | 2024-09-19T15:47:15Z | |
dc.date.available | 2024-09-19T15:47:15Z | |
dc.date.issued | 2018 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. Immunosuppressive and immunomodulating drugs are used during disease monitoring. Fingolimod is one of the immunomodulatory treatments used in MS patients. It is a therapeutic agent acting on lymphocytes. Latent varicella-zoster virus infections may occur in MS patients receiving fingolimod therapy. In this article, the information of two cases with varicella-zoster virus reactivation during fingolimod use were presented. © 2018 OMU | en_US |
dc.identifier.doi | 10.5835/jecm.omu.35.01.006 | |
dc.identifier.endpage | 30 | en_US |
dc.identifier.issn | 1309-4483 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopus | 2-s2.0-85105278426 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 27 | en_US |
dc.identifier.uri | https://doi.org/10.5835/jecm.omu.35.01.006 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/15069 | |
dc.identifier.volume | 35 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Ondokuz Mayis Universitesi | en_US |
dc.relation.ispartof | Journal of Experimental and Clinical Medicine (Turkey) | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Fingolimod Multiple sclerosis Varicella-zoster virus reactivation Zoster | en_US |
dc.title | Two multiple sclerosis cases developed herpes zoster during use of fingolimod | en_US |
dc.type | Article | en_US |